Group Results for the year ended 28 February 2022

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220808:nRSH2840Va&default-theme=true

RNS Number : 2840V  Inqo Investments Limited  08 August 2022

Inqo Investments Limited

 

Unaudited Group Results for the period ended 28 February 2022

 

CHAIRMAN AND CHIEF EXECUTIVE STATEMENT

 

Inqo Investments Limited ("Inqo" or "the Group") is a South African based
social impact company that acquires and invests in businesses that tackle
poverty and the social needs of low-income earners in Sub-Saharan Africa.

 

COMMENTARY

 

The Group remains in a good financial position with total assets of
R149,004,595 and minimal debt.

 

Subsequent to the year-end, additional funding and cash have been made
available to the Group as follows:

·      Directors' loan funds in the amount of R2,031,000 made available
to the company.

·      R1,440,000 that will be generated from the sale of the Group's
interest in its Bee Sweet Honey Investment.  These funds are due to be
settled on 31 August 2022, 31 October 2022 and 31 January 2023.

 

There are a number of challenges facing the Group currently, but despite these
challenges the directors of the company have assessed that it will continue as
a going concern.

 

The results for the year under review showed revenue of R3,872,007 (2021:
R4,214,583), reflecting a loss after tax of R12,614,587 (2021 a loss of
R11,563,674).  The loss for the year is reported after accounting for the
following operating costs:

 

                                          February 2022  February 2021

 Depreciation                             3,295,251      3,462,536

 Listing expenses                         581,917        839,653

 Directors' fees and salaries             696,000        658,000

 Professional fees                        629,847        514,891

 Impairments and fair value adjustments   2,357,326      2,189,219

 Provision for Doubtful Debts             529,069        270,134

 

The Group has suffered the consequences of the Covid-19 pandemic with lower
than expected earnings reported in this period. To counter the effects of the
pandemic, the Group has taken extensive steps to reduce costs with companies
in the Group adopting industry appropriate strategies to operate safely and
effectively under challenging conditions. The diverse nature of the Group
portfolio has meant that the impacts of the pandemic have varied across
investee companies from the severe impacts in the hospitality sector to far
less significant impacts to the agricultural sector. Now that most of the
world has relaxed Covid-19 restrictions, the companies in the Group are seeing
their operations returning to some form of normality, but whilst some were
able to grow despite the pandemic, others have yet to return to pre-Covid-19
business levels.

 

The directors of the holding company review the valuation placed on all income
earning assets annually to ensure that they reflect their fair value.  This
review was done on 28 February 2022 and, having conducted the review, the
directors are of the view that the Group's assets are reflected at fair
value.  In the process of carrying out this review it was decided that the
following value adjustments should be processed.

 

·      The Covid-19 pandemic hit the hospitality industry worldwide very
hard and at this stage the industry has not yet returned to pre-Covid-19
levels of travel.  Kuzuko Lodge, the Group's five-star Private Game Reserve,
has suffered like the rest of the hospitality industry worldwide.  The impact
of this is that monies owed by Kuzuko Lodge to Inqo have not been paid as
agreed and thus it has been agreed to make a provision for doubtful debts of
R1,750,937 against the total amount owing of R2,918,225.

 

·      When the directors conducted a review of the carrying values of
the various investments that the company has made it was agreed that a value
adjustment would need to be made in respect of its investments in Four One
Financial Services Limited and Bee Sweet Honey Limited.

 

Ø Four One Financial Services has struggled financially but managed to keep
afloat and, in the process, has defaulted on loan and interest payments.  The
consequences of this are that the full capital value of two of the loans with
a value of R620,722 in 2022 and 25% of the capital value amounting to R157,473
in 2021 have been impaired. A provision for doubtful debts has been raised
against interest owing of R770,812 in 2022 and R270,134 in 2021.

 

Ø Bee Sweet Honey has for the last three years struggled to produce the
levels of profit forecast due to poor conditions in the global honey market
which caused the US dollar based price of honey to fall. The result is that
while the company has continued trading, the value of Inqo's investment has
fallen and thus it was decided to impair the value of Inqo's investment in Bee
Sweet by R1,894,077.  In the last quarter of the 2021/2 financial year Bee
Sweet decided to re-align its business under new management and as a result
Inqo has opted to disinvest from the Bee Sweet operation in Zambia.  The
proceeds of the sales transaction will be paid to Inqo in the 2022/3 financial
year of the Group.

 

The negative impact of Global Warming that was experienced in the Eastern
Cape, where the properties owned by Inqo are situated, reached a high point in
September 2021 when drought impacts were exceptionally high.  We are pleased
to report that this position has reversed and that Inqo's property has had
good rainfall since October 2021.  In spite of this, game prices have not
fully recovered and thus the game, including the buffalo herd, had to be
impaired by an amount of R129,531 (2021: R566,323).

 

Land and buildings are required to be valued every two years by an independent
valuator in terms of Inqo's accounting policies.  The last formal valuation
was done in April 2021.  The company had the same valuator carry out a
desktop valuation this year and this valuation showed a 4% increase since
April 2021, thus the value stated in the company's books of account is
considered fair.

 

INVESTEE COMPANIES

 

Kuzuko Lodge (South Africa)

 

Kuzuko Lodge ("Kuzuko") re-opened to guests in September 2021 but has not yet
reached pre-Covid-19 trading levels.  A real improvement in bookings at the
Lodge is not expected to be felt until September 2022, when international
bookings for the traditional peak season, a significant source of revenue for
Kuzuko, are expected to return closer to pre-pandemic levels.

 

Pre-Covid, the Lodge had a staff complement of 64, the bulk of whom were drawn
from the local community.  Currently the staff complement is 28 who once
again are mainly drawn from the local community. The directors of the company
and the management company, Legacy Hotels and Resorts, have maintained contact
with members of the workforce who were retrenched/laid off and provided them
with food parcels during the period that the Lodge has been closed in recent
months.  The previously retrenched/laid off staff will be re-employed by the
Lodge as soon as occupancies allow.

 

Spekboom Trading (South Africa)

 

The company has to date replanted some 500 acres of degraded land with
spekboom, an indigenous shrub that naturally sequesters exceptionally high
levels carbon, creating 100 job opportunities in the process.

 

There has recently been a renewed interest in the carbon markets in response
to the growing global awareness on the impact of climate change with
nature-based solutions, such as spekboom, being a high priority.  Inqo has
started scaling up spekboom restoration activities now that the Covid-19
pandemic situation has largely been resolved providing valuable employment
opportunities as well as a positive environmental benefit. The outlook for
Spekboom Trading looks positive given the buoyant nature of the carbon markets
and global interest in reforestation projects.

 

Bee Sweet Honey (Zambia)

 

Inqo made a series of investments in the Bee Sweet commercial honey production
operation between 2016 and 2019.  Bee Sweet Honey contracts with rural
farmers to manage hives placed on farmers' land in return for a share of the
profit from the harvest.

 

Bee Sweet has not been able to operate profitably over the last few years due
to a combination of operational issues, challenges in the market and more
recently the global pandemic.  In the first quarter of the 2022 year, Bee
Sweet decided to change the way the company operated under new management and
as a result, Inqo has decided to exit its investment in Bee Sweet effective
May 2022.

 

Four-One Financial Services Limited (Uganda)

 

Inqo made an initial investment in 2017 and a further investment in 2018 in
Four-One Financial Services Limited ("Four-One"), a Ugandan based company that
provides micro-pension, savings and short-term loan products to the informal
sector.

 

Prior to the Covid-19 pandemic Four-One was performing well having endured
challenging operating conditions for the previous 18 months. In 2019, Four-One
diversified into offering micro business lending to support entrepreneurs. The
Covid-19 pandemic and resulting lockdowns had a severe impact in Uganda
causing an economic downturn, which had major knock-on effects for Four-One,
effectively ending their revenue stream.

 

During the middle of the pandemic, the Four-One management team took the brave
decision to pivot the business and leverage their existing experience in
finance and the technology platforms they had built to establish a new product
called Bitbricks. Bitbricks is a property development company building
affordable homes at 20% below the market rate. Micro real estate investors are
offered the chance to buy shares in the company and receive a share of the
profit on completion. The Four One team are in the process of building a
condominium development of 24 two-bedroom homes as a pilot project due to be
completed by the end of this year.

 

South Lake Medical Centre (Kenya)

 

South Lake Medical Centre ("SLMC") is a private healthcare provider in the
Naivasha region of Kenya serving predominantly low-income flower farm workers.
SLMC operate a 'hub and spoke' model around a 27-bed private referral-level
hospital with smaller satellite clinics based on surrounding flower farms and
in nearby population centres.  Inqo invested in SLMC in the 2019/20 year.

 

Currently, SLMC offers a range of in and outpatient services including
consultations, laboratory testing, radiology and pharmacy services. Following
this investment, SLMC expanded its operation with the inclusion of major and
minor surgical units that have recently been opened, making the SLMC facility
the most advanced hospital at the southern end of Lake Naivasha.  The
Naivasha region in Kenya is predominantly populated by low-income workers
working in the horticultural, agricultural and tourism industries.

 

The impact of Covid-19 has been economically challenging for SLMC.  The major
industry in the area being cut flowers for the European market - a sector that
has experienced variable sales during the Covid-19 pandemic period.
Fortunately, there is a strong vegetable growing industry in Naivasha that
continues to trade and provides medical appointments for SLMC. Through the
strong leadership of the management team, SLMC has endured the challenging
conditions of 2021 and 2022 and has continued to grow throughout. Patient
visit numbers have increased from 71,930 between Feb 20 - Feb 21 to 88,035
between Feb 21 and Feb 22. In addition to their regular service, SLMC operates
a health outreach program funded by the Waterloo Foundation, which grew from
serving 8,275 people in 2020, to 18,561 people in 2021. The hospital is now in
a strong position to achieve its objectives as the Kenyan economy begins to
recover.

 

Kentegra Biotechnology Limited (Kenya)

 

Kentegra Biotechnology Limited ("Kentegra") is a Kenyan based biotechnology
firm owned by the US holding company, Kentegra Biotechnology Holdings LLC.
Kentegra produces pyrethrum, a natural active ingredient from the
chrysanthemum flower, for the use in biocide, agricultural and pharmaceutical
pesticide markets.  The chrysanthemum flowers must be grown in specific
conditions to produce pyrethrum. These conditions are found only in a few
places around the world, predominantly East Africa (Tanzania, Uganda, Rwanda
and Kenya) and Australia.  With ideal growing conditions, Kenya was once the
largest producer of pyrethrum in the world until management issues and
synthetic alternatives led to a major decline in the nationalised industry in
the early 2000s.  In 2013, the Kenyan government liberalised the pyrethrum
sector in a concerted effort to revive the industry and support the growing
worldwide "organic" movement.  Kentegra is one of the six companies in Kenya
with a licence to produce pyrethrum.

 

As an essential industry, Kentegra had been able to operate normally and
continues to report demand despite the Covid-19 pandemic.  The senior
management team have responded quickly and professionally drawing up well
considered contingency plans for all eventualities and are re-evaluating the
situation on a continual basis.  Kentegra has shown a strong commitment to
both their smallholder farmer partners and their employees during this time,
going above and beyond to minimise the economic impact while ensuring safety
for the organisation. Kentegra's recently built factory has been successfully
in production for over a year now. At the end of this period, the company has
recruited over 10,000 farmers. Kentegra has also raised additional funds to
expand flower production and the expansion of their factory in order to
produce more active ingredient and so meet the increasing worldwide demand for
PRE (Pale Refined Extract).

 

Sanergy Incorporated (Kenya)

 

Sanergy Incorporated ("Sanergy") is a Nairobi based firm using an innovative
approach to safely recycle organic waste from agricultural, commercial,
sanitation, and municipal sources into insect protein, organic fertilizer and
biomass briquettes.

 

Since our investment into Sanergy Inc in October 2020, Sanergy have made
significant progress despite the challenges of COVID. Highlights include the
completion and opening of their Nairobi based factory, closing of a successful
Series B investment round in November 2020 and being recognized by the World
Economic Forum as one of its 15 BioDiverCITIES innovators - the only Africa
based company to receive this distinction.

 

In 2021, Sanergy recycled a total of 39,841 tons of organic waste and produced
131 tons of KuzaPro high protein animal feed from black soldier fly larvae,
2,162 tons of Evergrow fertilizer and 256 tons of biomass briquettes - some of
which were used to power the factory. Part of Sanergy's organic waste comes
from their Fresh Life franchisees who operate invaluable sanitation services
in the slum areas of Nairobi. In 2021, Sanergy had a total of 2,390 Fresh Life
franchisees, providing approximately 4,000 toilets to serve over 125,000
people per day.

 

At full capacity, Sanergy's Nairobi facility can recycle 90,000 tons of
organic waste per year. Sanergy's organic waste recycling service helps to
tackle environmental pollution caused by poor waste management and so its
associated healthcare issues. The by-products of Sanergy's recycling
activities also offer major environmental benefits with insect protein
offering a substitute for unsustainable fishmeal in animal feeds, organic
fertilizer offering a substitute to energy intensive nitrogen-based
fertilizers and biomass briquettes offering a sustainable alternative to
fossil fuels. Sanergy has plans to replicate their model across Africa and
Asia, which would produce significant environmental and social benefits
through a sustainable business model.

 

STOCK EXCHANGE LISTING

 

Aquis Exchange PLC (AIM: AQX) acquired the NEX Exchange in March 2020, which
has now been renamed The Aquis Stock Exchange (AQSE).  Shares on AQSE will
remain exempt from Capital Gains Tax and Inheritance Tax as they were on the
NEX Exchange.

 

OUTLOOK

 

Kuzuko Lodge - The Lodge reopened in September 2021 and while there has been a
regular flow of guests since that date, occupancies have not yet reached
pre-Covid-19 levels and are not expected to until the 2023/4 financial year.
There has been an upturn in booking enquiries experienced with booking
enquiries indicating that the property should see an increase in occupancy
levels from September 2022.

 

Bee Sweet Honey - Inqo has decided to exit its investment in Bee Sweet
Honey.  The amount agreed as to the exit payment will be paid to the company
during the 2022/23 year.

 

Spekboom Trading - Spekboom Trading continues to explore the options available
with a positive outlook given the currently buoyant carbon markets.

 

Four-One Financial Services - This business has been especially hard hit
because it serves the informal sector in Uganda with savings and short-term
loans products. The Covid-19 pandemic has been extremely challenging for the
informal sector in Uganda with many traders going out of business. Four One
have pivoted towards a new direction in the property development sector and it
will take time to establish if this move has been successful

 

South Lake Medical Centre - As an essential service, SLMC has been able to
continue trading throughout the pandemic. Despite the challenges, management
have been able to continue to implement development plans putting SLMC in a
strong position as the Kenyan economy begins to recover.

 

Kentegra Biotechnology - As an Agri-business, Kentegra was deemed an essential
service by the Kenyan government and has been able to continue operations
during the lockdown. During this period, the company has on-boarded a
significant number of new out-grower farmers as well as installed and
commissioned their new factory and made their first export sale. The company
currently has a strong order book.

 

Sanergy Incorporated - The company is receiving strong demand for its product
and is confident that this operation will expand as budgeted despite the
impact of the Covid-19 pandemic in Africa.

 

SUMMARY OF SOCIAL & ENVIRONMENTAL METRICS SINCE PROJECT COMMENCEMENT

 

·      39,000 acres of former farmland restored as a game reserve in a
region of endemic poverty in the poorest province in South Africa.

·      Increased VAT and income tax paid by Kuzuko year on year.

·      Currently, Kuzuko has a reduced staff complement due to Covid-19.

·      All staff living at Kuzuko in standard housing with flush
toilets, power, water and solar panels.

·      Conservation of 3 endangered species.

·      Re-wilded, bred and released 15 adult cheetah and 15 cheetah cubs
with new genetics into the metapopulation in Sub-Saharan Africa.

·      Reforestation of 500 acres of degraded land with spekboom
providing work for 100 part-time staff and sequestering carbon.

·      15 hectares of land between the reception area of the Lodge and
the Lodge area has have been replanted with various forms of vegetation to
recover heavily degraded land on the property. As part of this erosion
recovery process 100,000 spekboom cuttings have been planted

·      48,853 beehives in the field with positive impact on bee
populations and retention of forests.

·      2,100+ voluntary low-income savers in micro-pension and loan
schemes.

·      73,124 patient visits between January and December 2020 including
121 safe deliveries, 324 HIV patients receiving care and counselling, 1,204
infants immunised, 468 mothers receiving antenatal care and 8,275 people
receiving health education including, Covid-19 education, through community
outreach programs in Kenya.

·      Increased the economic livelihoods of over 17,000 farmers and
their families in Zambia and Kenya.

·      4,000 toilets serving 125,000 people daily in Nairobi.

 

STAFF

 

The directors would like to take this opportunity to thank all the operating
staff in the Group for their contribution and commitment to the Group's
objectives during this challenging time.

 

FINANCIAL INFORMATION

 

The financial information set out in this announcement does not constitute
statutory financial statements. This financial information has been extracted
from Inqo's unaudited group financial statements for the period ended 28
February 2022.

 

DIVIDEND

 

The company has not declared a dividend in the year ended 28 February 2022.

 

K.S
Tan
C.J Bertie

Chairman
                                        Chief Financial
Officer

 

Enquiries

 

 Inqo Investments Limited                                           Tel: +27 (0)83 6254069
 Chris Bertie, Chief Financial Officer and Chief Operating Officer  Email: cbertie@acland.co.za (mailto:cbertie@acland.co.za)

 Hobart Capital Markets LLP
 AQSE Corporate Adviser and Broker                                  Tel: +44 (0)20 7070 5665
 Dr Wang Chong                                                      Email: wang.chong@hobartcapital.com

Inqo Investments Limited Group

Condensed consolidated statement of profit or loss and other comprehensive
income

For the year ended 28 February 2022

                                                                    Group                                    Company

                                                                    2022               2021                  2022               2021
                                                                    R                  R                     R                  R
 Revenue                                                            3 872 007          4 214 583             386 160            698 491
 Cost of Sales                                                      (648 136)          (630 188)             -                  -
 Gross profit                                                       3 223 871          3 584 395             386 160            698 491
 Other income                                                       360 072            552 819               360 072            552 819
 Personnel expense                                                  (4 022 886)        (4 746 444)           (826 680)          (550 110)
 Depreciation & Amortisation                                        (3 295 251)        (3 462 536)           (2 777 934)        (2 883 328)
 Listing expenses                                                   (581 917)          (839 653)             (581 917)          (839 653)
 Professional fees                                                  (629 847)          (514 891)             (629 847)          (514 891)
 Provision for doubtful debts                                       (529 069)          (270 134)             (1 043 193)        (1 506 947)
 Impairment and fair value adjustment                            7  (2 357 326)        (157 473)             (2 357 326)        (157 473)

 Selling and administrative expenses                                (6 559 034)        (7 522 604)           (1 476 856)        (1 783 137)
 Operating loss                                                     (14 391 387)       (13 376 521)          (8 947 521)        (6 984 229)
 Inventory write-down                                               (186 464)          (372 151)             (186 464)          (372 151)
 Fair value adjustment                                              56 933             (194 172)             56 933             (194 172)
 Net financing income                                               299 547            502 942               783 326            721 908
 Finance income                                                     460 595            692 482               811 063            761 740
 Finance expense                                                    (161 048)          (189 540)             (27 736)           (39 832)
                                                                                                                                (6 828 644
 Loss before taxation                                               (14 221 371)       (13 439 902)          (8 293 726)        (6 828 644)
 Taxation                                                           1 606 784          1 876 228             1 606 784          1 876 228
 Loss for the year                                                  (12 614 587)       (11 563 674)          (6 686 942)        (4 952 416)
 Loss attributable to:
 Equity holders                                                     (12 380 267)       (11 272 203)          (6 686 942)        (4 952 416)
 Non-controlling interest                                           (234 320)          (291 471)             -                  -
                                                                    (12 614 587)       (11 563 674)          (6 686 942)        (4 952 416)

 

 

Inqo Investments Limited Group

Condensed consolidated statement of profit or loss and other comprehensive
income

For the year ended 28 February 2022

                                                                                  Group                                     Company

                                                                                  2022               2021                   2022               2021
                                                                                  R                  R                      R                  R

 Other comprehensive income - Items that will not subsequently be reclassified
 to profit or loss:

                                                                                  -                  (1 137 167)            -                  (1 137 167)
 Revaluation of land and buildings                                                -                  (1 465 422)            -                  (1 465 422)
 Deferred tax on revaluation                                                      -                  328 255                -                  328 255

 Total other comprehensive income for the year                                    -                  (1 137 167)            -                  (1 137 167)

 Total comprehensive income for the year                                          (12 614 587)       (12 700 841)           (6 686 942)        (6 089 583)

 Total comprehensive income attributable to:
 Equity holders                                                                   (12 380 267)       (12 409 370)           (6 686 942)        (6 089 583)
 Non-controlling interest                                                         (234 320)          (291 471)              -                  -
                                                                                  (12 614 587)       (12 700 841)           (6 686 942)        (6 089 583)

 Loss per share (rands)                                                           (0.85)             (0.78)

 Diluted loss per share (rands)                                                   (0.85)             (0.78)

 Inqo Investments Limited Group
 Condensed consolidated statement of financial position
 At 28 February 2022
                                                                                                                                                              Group                                          Company
                                                                                                                                                              2022                    2021                   2022                   2021
                                                                                                                                                              R                       R                      R                      R
          Assets
          Non-current assets                                                                                                                                  137 275 303             143 346 953            148 514 260            149 017 592
          Property, plant and equipment                                                                                                                       128 440 653             131 315 802            128 088 946            130 644 236
          Intangible assets                                                                                                                                   3 622                   8 517                  -                      -
          Right of use Asset                                                                                                                                  362 693                 505 421                -                      -
          Trade and other receivables                                                                                                                         -                       -                      1 167 288              1 236 813
          Loans to subsidiaries                                                                                                                               -                       -                      10 979 026             5 808 665
          Other investments                                                                                                                                   8 468 335               11 517 213             6 800 615              9 849 493
          Investments in subsidiaries                                                                                                                         -                       -                      1 478 385              1 478 385
          Current assets                                                                                                                                      10 396 005              12 622 630             8 303 721              10 274 635
          Inventories                                                                                                                                         4 058 788               4 264 824              3 426 680              3 701 144
          Trade and other receivables                                                                                                                         2 743 619               3 139 521              2 298 951              2 626 845
          Other                                                                                                                                               -                       440 388                -                      440 388
          investments
          Biological assets                                                                                                                                   2 921 627               2 864 694              2 009 040              1 952 107
          Cash and cash equivalents                                                                                                                           671 971                 1 913 203              569 051                1 554 151
          Assets held for sale                                                                                                                                1 333 287               5 695 345              1 333 287              5 695 345
          Assets held for sale                                                                                                                                1 333 287               5 695 345              1 333 287              5 695 345

          Total current assets                                                                                                                                11 729 492              18 317 975             9 637 008              15 989 980

          Total assets                                                                                                                                        149 004 595             161 664 928            158 151 268            164 987 572

          Equity and liabilities
          Capital and reserves
          Share capital                                                                                                                                       72 584 925              71 809 195             72 584 925             71 809 195
          Share premium                                                                                                                                       87 585 270              86 294 138             87 585 270             86 294 138
          Revaluation reserve                                                                                                                                 72 015 535              72 015 535             72 015 535             72 015 535
          Accumulated loss                                                                                                                                    (93 964 328)            (81 584 061)           (77 286 528)            (70 599 586)
          Equity attributable to equity holders of Inqo Investments Limited                                                                                   138 221 402             148 534 807            154 899 202            159 519 282
          Non-controlling interest                                                                                                                            247 844                 482 164                -                      -
          Total equity                                                                                                                                        138 469 246             149 016 971            154 899 202            159 519 282
          Non-current liabilities                                                                                                                             2 903 675               4 632 671              2 512 847              4 092 252
          Loans from related parties                                                                                                                          902 409                 875 030                774 735                747 356
          Deferred tax liability                                                                                                                              1 738 112               3 344 896              1 738 112              3 344 896
          Lease liability                                                                                                                                     263 154                 412 745                -                      -
          Current liabilities                                                                                                                                 7 631 674               8 015 286              739 219                1 376 038
          Bank overdraft                                                                                                                                      688 491                 920 267                -                      -
          Trade and other payables                                                                                                                            6 770 068               6 695 255              739 219                1 376 038
          Provision                                                                                                                                           -                       253 341                -                      -
          Lease Liability                                                                                                                                     173 115                 146 423                -                      -

          Total liabilities                                                                                                                                   10 535 349              12 647 957             3 252 066              5 468 290
          Total equity and liabilities                                                                                                                        149 004 595             161 664 928            158 151 268            164 987 572

Inqo Investments Limited Group

Statements of cash flows

For the year ended 28 February 2022

 

                                                                                  Group                                  Company
                                                                                  2022               2021                2022               2021
                                                                                  R                  R                   R                  R
 Cash utilised by operations                                                      (9 099 312)        (12 199 004)        (4 552 374)        (6 814 523)
 Interest Received                                                                186 687            692 482             185 955            681 027
 Interest Paid                                                                    (72 467)           (189 540)           -                  (39 832)
 Net cash flow from operating activities                                          (8 985 092)        (11 696 062)        (4 366 419)        (6 173 328)

 Cash flows from investing activities
 Acquisition of subsidiary                                                        -                  -                   -                  (1 000)
 Increase in loans to subsidiary                                                  -                  -                   (4 819 162)        (5 007 665)
 Acquisition of other investments                                                 -                  (1 667 720)         -                  -
 Unrealised forex loss                                                            (177 121)          282 249             (177 121)          282 249
 Loan repaid by other investments                                                 733 980            38 975              733 980            38 975
 Acquisition of property, plant and equipment                                     (254 874)          (1 870 529)         (222 644)          (1 812 698)
 Proceeds on disposal of biological assets                                        186 957            -                   186 957            -
 Acquisition of intangible assets                                                 -                  (3 999)             -                  -
 Proceeds on disposal of property, plant and equipment                            5 612 447          376 214             5 612 447          376 214
 Net cash flow from investing activities                                          6 101 389          (2 844 810)         (1 314 457)        (6 123 925)

 Cash flows from financing activities
 Proceeds from shares issued                                                      2 066 862          -                   2 066 862          -
 Repayment of finance lease                                                       (192 615)          (137 978)           -                  -
 Loans made to related parties                                                    -                  -                   -                  -
 Net cash flow from financing activities                                          1 874 247          (137 978)           2 066 862          -

 Net movement in cash and cash equivalents                                        (1 009 456)        (14 678 850)        (985 100)          (12 297 253)
 Cash and cash equivalents at beginning of year                                   992 936            15 671 786          1 554 151          13 851 404
 Cash and cash equivalents at end of year                                         (16 520)           992 936             569 051            1 554 151

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NEXPPMBTMTIMBPT

Recent news on Inqo Investments

See all news